important then to treat both the primary disease as well as coexisting depression. 10, 11 In the epilepsy population, coexisting depressive symptoms leads not only to a substandard quality of life, but can also predict poorer seizure control following medical intervention. 12 In turn, poor seizure control also predicts failure of other treatments. 13 Coping strategies consist of behaviors, primarily management and problem-solving techniques, that are designed to reduce patient burden and are often implemented to manage stressful situations.
14 Various positive strategies may incorporate spirituality as well as emotional support from friends and family, the utilization of distracters, or meditative techniques. On the other hand, negative coping reactions may also be utilized, including denial, self-blame, or even alcohol or drug use. These various coping styles can also be categorized as being either problem-or emotion-focused. Problem-focused techniques, such as planning, are those that actively manage stressors. In contrast, emotion-focused coping strategies, such as substance abuse, are used in an attempt to avoid dealing directly with stressful situations and often lead to patient denial and avoidance. 15, 16 In other disease states such as heart failure, it has been shown that maladaptive coping mechanisms such as denial and disengagement are encountered more often among patients who are depressed. 17 What is not known is whether depression influences coping strategies across the epilepsy population.
In this study, we surveyed epilepsy patients at a Level 4 epilepsy center in Jacksonville, Florida, USA, to determine the coping mechanisms utilized by those with depression, and compared these with the coping reactions used by patients who were not depressed. The coping mechanisms employed by patients with epilepsy and depression have not been previously studied and needs to be determined for several reasons. First, it is important to know whether being depressed is associated with unhealthy coping reactions; and if so, whether this may provide one explanation for the poorer seizure control and inferior quality of life encountered in this subset of epilepsy patients. Knowing the coping reactions employed by epilepsy patients who are depressed can also be of value to caregivers as they help patients deal with an already stressful situation. Above all, realizing that depression is associated with unhealthy coping reactions should provide additional impetus to more aggressively and effectively manage this often-encountered co-morbidity in the epilepsy population.
Methods
This study is an extension of a previous work that was detailed in an earlier publication about the coping strategies of individuals with epilepsy. 18 Two hundred continuous individuals seen at the Comprehensive Epilepsy Program-UFHSCJ outpatient clinics were surveyed for this study. These patients were adults with a diagnosis of localization-related (partial) epilepsy who had no history of psychogenic, non-epileptic seizures. Patients were their own primary caregivers and could complete the survey without assistance. The survey contained different demographic and clinical variables that included age, gender, marital status, ethnicity (Hispanic versus non-Hispanic), race, educational attainment, annual household income, driving status, disability status, employment status, age at seizure onset, seizure duration, seizure frequency, presence of convulsions, occurrence of waking seizures, seizure etiology, number of AEDs (antiepileptic drugs) they are currently taking, and severity of side effects from their current AED regimen. Various psychosocial instruments in the survey were also utilized. These included the Neurological Institute Disorders Depression Inventory for Epilepsy (NIDDI-E), 19 Quality of Life in Epilepsy-10 Inventory (QOLIE-10), 20 Beliefs About Medicines Questionnaire-Specific (BMQ-S), 21 Sheehan Disability Scale (SDS), 22 23 We also administered the Brief Coping with Problems Experienced (Brief-COPE) Inventory and used disposition-type questions to assess the subjects' coping strategies. 24, 25 For this study, we determined whether depression was significantly associated with particular coping strategies among individuals with epilepsy. We defined individuals with depression as having a score >15 on the NIDDI-E as this has a sensitivity of 81%, specificity of 90%, and a positive predictive value of 62% for diagnosing a major depression. 19 The Institutional Review Board of the University of Florida Health Sciences Center/Jacksonville (UFHSCJ) approved this study.
Statistical analysis
Statistical analysis was performed using SPSS 15.0 TM at a 5% level of significance using a 2-tailed test. The null hypothesis was that depressed and non-depressed did not significantly differ across the various demographic, clinical, and psychosocial parameters measures, nor did they differ according to coping strategies employed. We enrolled 200 patients for the study. Based on this, the categorical comparison of substrata (i.e. comparing coping strategies of depressed and non-depressed subjects) had a power of about 80% for detecting differences of a moderate effect size. Comparisons and analysis using interval data also had sufficient power to detect operationally meaningful differences even within substrata.
We first determined whether depressed and non-depressed patients differed from one another across various demographic, clinical, and psychosocial, non-coping variables. We tested for the equality of means for interval variables using ANOVA (transforming certain data to satisfy the assumptions of ANOVA). We tested ordinal variables using Mann Whitney and analyzed categorical data with chi-square statistics. Adjusted standardized residuals (ASR) were used as the post hoc comparison method.
We then determined whether depressed and non-depressed individuals differed across the various coping strategies using selected items from the Brief-COPE whose question-pairs had good internal consistency based our the earlier study (Cronbach's alpha of at least 0.5). Included were the coping reactions of substance abuse, religion, humor, instrumental support, acceptance, denial, and emotional support, positive reframing, and planning. Active coping, self-blame, behavioral disengagement, venting and selfdistraction were excluded from analysis due to poor internal consistency. We also determined whether depressed and nondepressed individuals differed on the two main coping clusters we earlier identified using Principal Component Analysis: Factor 1 (engagement-type coping strategies) and Factor 2 (disengagement-type coping strategies). 17 Multiple linear regression (MLR) was performed to determine whether coping strategies that distinguished depressed and nondepressed patients on univariate analysis retained significance in the simultaneous context of the other significant demographic, clinical, and psychosocial variables.
We also performed subgroup analysis of depressed individuals with epilepsy in order to determine whether coping strategies that were preferentially utilized in this subgroup were associated with important outcome measures such as seizure frequency and quality of life.
Results
We detailed the demographic and clinical data for this study in an earlier publication. In summary, the mean age of subjects was 41 years and 36% were males. More than half were Caucasians while one-third were African-Americans. The majority had no more than a high school education and more than half had an annual household income of less than $10,000. Most respondents did not operate a motor vehicle and more than half received disability benefits. The vast majority were not working.
The mean age of seizure onset was 23 years and average seizure duration was 19 years. A quarter of subjects had less than one seizure a year. The majority of subjects experienced generalized tonic-clonic seizures and seizures while awake. More than half of subjects did not have an identifiable cause for their seizures. Subjects were on a varied number of seizure medications but more than half did not experience any medication-related side effects. The mean NIDDI-E and QOLIE-10 scores were 13.2 and 33.5 respectively. The mean BMQ-S score was 3.8 while average SDS total score was 13.9. More than half the subjects did not experience serious issues with health literacy. 18 Of the 200 patients included in this study, one subject did not complete the NIDDI-E and was excluded from further analysis. Seventy-one subjects (37%) had a major depression (NIDDI-E score of >15) while 128 did not. On univariate analysis, not driving, not working, higher seizure frequency, having convulsive seizures, higher (poorer) QOLIE-10 scores and higher (worse) SDS-scores were significantly associated with being depressed (Table 1) . When examining coping strategies, depressed individuals had higher scores on denial compared to non-depressed patients (Table 2) .
Using multiple linear regression, the association between the use of denial and being depressed remained statistically and independently significant in the simultaneous context of the other demographic, clinical, and psychosocial variables found to be significant on univariate analysis (Table 3) .
On subgroup analysis, the use of denial coping among depressed patients with epilepsy was not statistically associated with QOLIE-10 scores (p = 0.95; Pearson correlation, using transformed data: SQRT Â (45 minus QOLIE-10 score)). The mean denial coping scores of patients who had daily and weekly seizures were higher than those who had less frequent seizures (Fig. 1) . However, this did not reach statistical significance (p = 0.44; ANOVA). This analysis was limited as the number of patients analyzed (n = 71) only had a power of 80% for detecting differences of a large effect size.
Discussion
Coping describes the manner by which people deal with stressful events and is often a result of multidimensional processes determined by environmental conditions, cognitive abilities, and personality dispositions. 26 Our study investigated the coping mechanisms employed by patients with epilepsy who also had concomitant depression. Our study results reveal that more than a third of our patients have a major depression (defined as a NIDDI-E scores >15) and that being depressed was associated with increased use of denial coping. Also, being depressed was associated with poorer quality of life, higher disability scores, higher convulsions, higher frequency of seizures, not working, and not driving. Among depressed epilepsy patients, those with more frequent seizures had higher mean denial coping scores although the association did not reach statistical significance and may have been limited by the small sample size. Interestingly, variables such as epilepsy duration or the number of AEDs used did not distinguish depressed from non-depressed individuals.
Our results is one of many that emphasize the high prevalence of psychiatric co-morbidities among individuals with epilepsy [4] [5] [6] [7] and also indicates that compared to non-depressed individuals, those who are depressed place greater reliance on denial as a coping strategy. This is likely of no surprise as denial has been traditionally regarded as a maladaptive form of coping employed by individuals across a variety of medical conditions in order to reduce the tension and anxiety that occur with having an illness. 27 Brajkovic and colleagues 28 surveyed individuals with multiple sclerosis to determine their coping styles and related these to ongoing symptoms of depression and anxiety. The use of denial as a coping reaction was associated with worsening depression and anxiety as well as increased fatigue. A similar survey was conducted by Burker and colleagues 29 on a group of patients who were being evaluated for heart transplant. Of all coping strategies, denial had the strongest association with depression and emotional distress. Among older individuals with heart failure, it was shown that the use of maladaptive coping reactions such as denial, self-blame, and self-distraction were associated with poor quality of life and the presence of depressed symptoms. 30 The impact of the use of denial as a coping mechanism goes beyond affective issues and may directly impact care. In a study of homosexual females, Vyavaharkar and colleagues 31 determined that individuals with coping mechanisms that focused on avoidance and denial also had poorer medication adherence. The higher mean denial coping scores seen among our depressed epilepsy patients who have more frequent seizures is somewhat intriguing and raises the question of whether the use of this maladaptive strategy is one of the key reasons for the link between being depressed and poor clinical outcomes. 4, 5 Future studies with larger sample sizes will be necessary to confirm whether this association is statistically significant. Understanding the coping reactions employed by individuals with epilepsy is important and should lead to the development of treatment protocols designed to help improve their quality of life as well as their ability to deal with their disorder. An example of this can be found in a study by Carrico and colleagues 32 that implemented a stress management program for HIV+ homosexual males receiving highly active antiretroviral therapy (HAART). One intervention arm consisted of a 10-week cognitive behavioral stress training with medication adherence training (CBSM+MAT) while the other arm consisted only of medication adherence training. Though no changes in self-reported adherence was seen among the two groups, the authors demonstrated that patients in the CBSM+MAT arm had significantly depressed mood and decreased use of denial coping during the intervention period. Using path analysis, an initial high reliance on denial coping at baseline was associated with a significant reduction in depressed mood after the 10-week intervention. Our study has several limitations. Our research was conducted in a primarily urban region in the southeast United States that caters to an inner city population in the Southeastern United States. Thus, it may be difficult to replicate our study findings in other epilepsy populations with a different demographic profile. Secondly, the data collected were from subjects who consented to participating in the study and were required to self-report their information while answering the questionnaire. Patients enrolled into the study had to be able to care for themselves and answer the questionnaire without assistance. These conditions allow for the possibility of both sampling and responder bias based on the patients' own perception of the questions and perhaps even their own personal biases. Third, the measurement tool used for evaluating our patients' coping strategies was the Brief-COPE. Thus, the coping reactions assessed in this study were limited to those measured by this tool. Future researches are necessary in order to broaden our understanding of the coping strategies employed by individuals with epilepsy and to determine how this impacts treatment outcomes. This would include comparing the coping strategies of depressed individuals with epilepsy to those who do not have epilepsy but are likewise depressed. This would allow us to determine whether the coping reaction is a function of having epilepsy, or determined primarily by the subject's depressed state. Another research should look at the effects treatment regimens for depressed individuals with epilepsy (i.e. pharmacologic versus behavioral therapy) may have on their coping strategies. Determining whether epilepsy type influences coping strategies is another interesting field of research. Lastly, other variables that could have influenced coping techniques, such as medication adherence, should be examined in future studies.
The results of this study highlight an important, and previously unknown, characteristic of epilepsy patients who simultaneously experience seizures while attempting to manage their depression. Future studies are needed in order to confirm whether the use of maladaptive coping strategies in these patients adversely affect treatment outcomes. On an individual level, understanding how patients cope with their condition provides some assistance to love ones and caregivers as they help patients deal with their condition on a daily basis. Above all, this study provides additional impetus on the need to more effectively identify and aggressively treat depression among individuals with epilepsy. Error Bars represent 95% co nfidence in tervals Fig. 1 . The association between seizure frequency and use of denial coping in epilepsy patients who are depressed. Although the mean denial coping scores were higher among patients with daily and weekly seizures, this did not reach statistical significance (p = 0.44; ANOVA) and may have been limited by the small sample size (n = 71).
